Delivery Order SPE2DB22D3301-SPE2DB25FX8MR

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,501.31 firm fixed-price delivery order is for the supply of Loestrin 21 1.5-30 tablets, a contraceptive medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,040.16 firm fixed-price delivery order is for the supply of Loestrin FE 1.5-30 tablets, a contraceptive medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,587.97 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 140S, a contraceptive medication. The contract has an ultimate completion date of December 10, 2024. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,170.59 and is for the delivery of Loestrin Fe 1-20 tablet 28s, a contraceptive medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier of medical products to the U.S. government. The $2,795.78 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a prescription contraceptive medication. The award has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $27,391.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loestrin 21 1-20 tablet 21s, a generic oral contraceptive. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,110.45 firm fixed-price delivery order covers the supply of LOESTRIN FE 1.5-30 TABLET 28S, a pharmaceutical product, with a period of performance through March 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,571.54 firm fixed-price delivery order contract is for the supply of LOESTRIN FE 1-20 TABLET 28S, a hormonal contraceptive medication. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,578.83 Firm Fixed Price Delivery Order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a generic birth control medication. The contract has an ultimate completion date of March 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $3,650.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a delivery order for LO LOESTRIN FE 1-10 TABLET 28S, a type of oral contraceptive medication. The contract has an ultimate completion date of January 14, 2025 and uses a firm fixed price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8MR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,780.41 firm fixed-price delivery order contract is for the supply of Loestrin FE 1-20 tablets, a contraceptive medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 4/17/25, 8:44 AM